Clinical trial
A Phase I Trial of TNF-Bound Colloidal Gold (CYT-6091) by Intravenous Administration in Subjects With Advanced Solid Organ Malignancies
NCT00356980 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Trial of TNF-Bound Colloidal Gold (CYT-6091) by Intravenous Administration in Subjects With Advanced Solid Organ Malignancies
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2006
- Completion date
- April 30, 2009
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
unspecified adult solid tumor, protocol specific